Translating research into discoveries which will help patients, is a challenging process. Find information on shortening the path from research to clinic.
Immuno-oncology is one of the most dynamic areas of cancer research. Learn how we are helping accelerate discovery with simplified workflows for flow cytometry, biomarker profiling, and cell imaging.
We support our customers from discovery through to commercialization with a full suite of products and services. Learn more about our Cell Therapy Systems offerings and how we can help streamline the path from discovery to cure.
No records were found matching your criteria
|Article||Precision Medicine Leaders Gather in Beijing for First China-U.S. Precision Medicine Summit||Translational Research, Targeted Therapeutics, Population Profiling, Molecular Diagnostics|
|Article||The Future of Mass Spectrometry in Healthcare||Translational Research|
|e-book||A Dose of Technology for Precision Medicine eBook||Translational Research|
|Blog||What is Immuno-Oncology?||Translational Research|
|Blog||A Huge Step Forward for Immunotherapy: First Ever FDA Approved CAR-T Cell Therapy||Translational Research, Targeted Therapeutics|
|Brochure||Streamline the Path form Discovery to Cure: Cell Therapy Solutions for Every Step||Translational Research, Targeted Therapeutics|
|Brochure||Empowering Technologies for Immuno-Oncology Research||Translational Research|
|Webinar||Thermo Fisher Scientific Cell Therapy Capabilities||Translational Research|
|Blog||CRISPR-Cas9 Off-Target Effects||Translational Research|
|Blog/ e-book download||CRISPR-Cas9 is Revolutionizing Gene Editing||Translational Research|
|Interview||Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies||Translational Research, Targeted Therapeutics|
|Article||The Translational Proteomics Workflows Driving Biomarker Research Beyond Discovery||Translational Research|